Polysomnography in transgenic hSOD1 mice as Down syndrome model

Journal of Neural Transmission, Supplement

Volumn , Issue 67, 2003, Pages 165-171

  Colas, D ^a   London, J ^b   Cespuglio, R ^a   Sarda, N ^a  

^a UNIVERSITÉ LYON 1   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER; SUPEROXIDE DISMUTASE; ZINC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARCHITECTURE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MODEL; DOWN SYNDROME; ELECTROENCEPHALOGRAM; HETEROZYGOTE; HOMEOSTASIS; MALE; MOUSE; NONHUMAN; PHENOTYPE; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RECORDING; REM SLEEP; SLEEP DEPRIVATION; SLEEP WAKING CYCLE; TRANSGENIC MOUSE;

EID: 1542719730     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6721-2_15     Document Type: Article

References (25)

1. Andreou G, Galanopoulou C, Gourgoulianis K, Karapetsas A, Molyvdas P (2002) Cognitive status in Down syndrome individuals with sleep disordered breathing deficits (SDB). Brain Cogn 50: 145-149
2. Avrahan KB, Sugarman H, Rotshenker S, Groner Y (1991) Down's syndrome: morphological remodelling and increased complexity in the neuromuscular junction of transgenic CuZn-superoxide dismutase mice. J Neurocytol 20: 208-215
3. Caviedes P, Ault B, Rapoport SI (1990) The role of altered sodium currents in the action potential abnormalities of cultured dorsal root ganglion neurons from trisomy 21 (down's syndrome) human fetuses. Brain Res 510: 229-236
4. Chan PH, Chu L, Chen SF, Carlson EJ, Epstein CJ (1990) Attenuation of glutamate-induced neuronal swelling and toxicity in transgenic mice overexpressing human Cu/Zn-superoxide dismutase. Acta Neurochir [Suppl]51: 245-247
5. Clément P, Gharib A, Cespuglio R, Sarda N (2003) Changes in the sleep-wake cycle architecture and cortical nitrix oxide release during ageing in the rat. Neurosci 116: 863-870
6. Colas D, London J, Gharib A, Cespuglio R, Sarda N (2003) Sleep wake architecture in Down syndrome murine models. Neurobiol Dis (in press)
7. Dierssen M, Fillat C, Crnic L, Arbones M, Florez J, Estivill X (2001) Murine models for Down syndrome. Physiol Behav 73: 859-871
8. Diomedi M, Curatola P, Scalise A, Pacidi F, Caretto F, Gigli GL (1999) Sleep abnormalities in mentally retarded autistic subjects: Down's syndrome with mental retardation and normal subjects. Brain Dev 21: 548-553
9. Epstein CJ (1995) In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular basis of inherited disease. McGraw Hill, New York, p 749
10. Epstein CJ, Avraham K, Lovett M, Smith S, Elroy-Stein O, Rotman G, Bry C, Groner Y (1987) Transgenic mice with increased CuZn superoxide dismutase activity: animal model of dosage effects in Down sydrome. Proc Natl Acad Sci USA 84: 8044-8048
11. Gahtan E, Auerbach JM, Groner Y, Segal M (1998) Reversible impairment of long-term potentiation in transgenic Cu/Zn-SOD mice. Eur J Neurosci 10: 538-544
12. Groner Y, Lieman-Hurwitz J, Dafni N, Sherman L, Levanon D, Bernstein Y, Danciger E, Elroy-Stein O (1985) Molecular structure and expression of the gene locus on chromosome 21 encoding the Cu/Zn superoxide dismutase and its relevance to Down syndrome. Ann NY Acad Sci 450: 133-156
13. Grubar JC, Gigli GL, Colognola RM, Ferri R, Musumeci SA, Bergonzi P (1986) Sleep patterns of Down's syndrome children: effects of butoctamide hydrogen succinate (BAHS) administration. Psychopharmacol 90: 119-122
14. Head E, Azizeh BY, Lott IT, Tenner AJ, Cotman CW, Cribbs DH (2001) Complement association with neurons and beta-amyloid deposition in the brains of aged individuals with Down syndrome. Neurobiol Dis 8: 252-265
15. Kola I, Herzog PJ (1998) Down syndrome and mouse models. Curr Opin Genet Dev 8: 316-321
16. Lejeune J, Gautier M, Turpin R (1959) Etude des chromosomes somatiques de neufs enfants mongoliens. CR Acad Sci 248: 1722-1724
17. Levanon A, Tarasiuk A, Tal A (1999) Sleep characteristics in children with Down syndrome. J Pediatr 134: 755-760
18. Nabarra B, Casanova M, Paris D, Nicole A, Toyama K, Sinet PM, Ceballos I, London J (1996) Transgenic mice overexpressing the human Cu/Zn-SOD gene: ultrastructure studies of a premature thymic involution model of Down's syndrome (trisomy 21). Lab Invest 74: 617-626
19. Paris D, Toyama K, Magarbane A, Casanova M, Sinet PM, London J (1996) Rapid fluorescence in situ hybridation on interphasic nuclei to discriminate between homozygous and heterozygous transgenic mice. Transgenic Res 5: 397-403
20. Pearlman C, Greenberg R (1972) Brief REM sleep deprivation impair consolidation in complex learning in rats. Psychophysiology 9: 109-110
21. Przedborski S, Kostic V, Jackson-Lewis V, Naini AB, Simonetti S, Fahn S, Carlson E, Epstein CJ, Cadet JL (1992) Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced neurotoxicity. J Neurosci 12: 1658-1667
22. Schickler M, Knobler H, Avraham KB, Elroy-Stein O, Groner Y (1989) Diminished serotonin uptake in platelets of transgenic mice with increased Cu/Zn-superoxide dismutase activity. EMBO 8: 1385-1392
23. Sinet PM, Lavelle F, Michelson AM, Jerome H (1975) Superoxide dismutase activities of blood platelets in trisomy 21. Biochem Biophys Res Com 67: 904-909
24. Tobler I (2000) Phylogeny of sleep regulation. In: Kryger MH, Roth T, Dement WC (eds) Principles and practice of sleep medicine. Saunders, Philadelphia, p 72
25. Wisniewski HM, Rabe A (1985) Discrepancy between Alzheimer-type neuropathology and dementia in persons with Down's syndrome. Ann NY Acad Sci 477: 247-260